SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heavy trading volume as investors debate its ability to convert significant AI and data-center capital expenditures into sustainable cash flow. While some traders view recent price action as a technical bottoming and a potential asymmetric buying opportunity, others remain cautious due to concerns over high debt levels and the broader sell-off impacting the software sector.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as market participants weigh its depressed valuation and aggressive share buybacks against ongoing concerns regarding branded checkout growth and leadership silence. Investors are heavily debating the stock's potential for a significant re-rating, with active community discussions centering on prospective buyout rumors, new partnership integrations, and speculation about strategic pivots under the new CEO.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a historic rally driven by significant new partnerships with tech giants like Google and SpaceX, alongside government-backed initiatives, leading to intense debate over whether the stock is a long-term growth play or an overextended momentum trap. The community is actively discussing the stock's parabolic climb toward all-time highs, with intense speculation on potential pullbacks, earnings expectations, and the impact of geopolitical developments on chip supply chains.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is surging toward record highs, driven by its upcoming inclusion in the Nasdaq-100 and relentless demand for high-performance memory chips in AI data centers. While the community remains divided between those expecting further gains and others warning of an "AI bubble," market participants are heavily focused on the index rebalance and potential volatility from geopolitical tensions.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is currently trending due to a major breakthrough, securing over $4 million in U.S. government contracts to advance its semiconductor platform for quantum and high-speed data communications. The community is actively discussing this news as a significant validation of the company's proprietary technology, with many investors debating the long-term potential for commercial scaling, sector-wide impact, and the stock's future trajectory following recent market volatility.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is trending as investors debate the company's aggressive Bitcoin treasury strategy and the potential impact of its proposed T-Strive Digital Credit ETF (DGCR). While community sentiment remains highly polarized, many traders are actively discussing the stock's high volatility and its correlation to Bitcoin's price action, with some viewing recent pullbacks as accumulation opportunities ahead of a potential recovery.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is currently in the spotlight as investors digest mixed quarterly results and analyze the bank's exposure to private credit amid broader sector volatility. Market participants are actively debating the bank's ability to navigate current interest rate environments while monitoring how its investment banking and trading performance will influence the broader financial sector's trajectory.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest the FDA's decision to award a National Priority Voucher to its lead oncology candidate, daraxonrasib, while the community intensely debates its competitive positioning against other RAS-targeting peers in the pancreatic cancer space. Discussions are heavily focused on the drug's transformational Phase 3 clinical data, with analysts frequently raising price targets as expectations mount for a major commercial launch and long-term M&A potential.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and massive short liquidations, driving the token to record highs amid intense community debate over whether it is a legitimate high-growth asset or a speculative pump-and-dump scheme. Investors are actively discussing the project's web3 music event utility and upcoming partnership rumors while expressing deep caution over the high concentration of holdings and the potential for a sharp correction.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding is under intense investor scrutiny following a volatile slide and a federal lawsuit filed against multiple parties for the alleged unauthorized sale of its Datavault AI collateral shares. Community sentiment remains deeply divided, with many retail investors expressing frustration over the company's opaque financial status and ongoing dilution, while a vocal contingent continues to search for signs of a turnaround or strategic buyouts despite persistent sell-side pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Increases By 71.2%

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,337,824 shares, an increase...

HC Wainwright Issues Positive Forecast for OVID Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Equities research analysts at HC Wainwright boosted their Q2 2026 earnings per share (EPS) estimates for Ovid Therapeutics in a research note issued on...

Ovid Therapeutics (NASDAQ:OVID) Price Target Raised to $4.00

HC Wainwright boosted their price objective on shares of Ovid Therapeutics from $2.00 to $4.00 and gave the company a "buy" rating in a research report on Thursday...

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated a "buy" rating and issued a $4.00 price objective on shares of Ovid Therapeutics in a report on Thursday...

Lifesci Capital Has Negative Estimate for OVID Q1 Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Analysts at Lifesci Capital dropped their Q1 2026 earnings per share estimates for Ovid Therapeutics in a research note issued to investors on Tuesday...

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have received an average rating of "Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports...

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to Hold

Wall Street Zen raised shares of Ovid Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Wedbush Forecasts Strong Price Appreciation for Ovid Therapeutics (NASDAQ:OVID) Stock

Wedbush lifted their target price on Ovid Therapeutics from $5.00 to $7.00 and gave the stock an "outperform" rating in a research note on Friday...

Ovid Therapeutics Q4 Earnings Call Highlights

Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct...

Here's Why Ovid Therapeutics Stock Popped Higher Today

Key PointsOV329 may be safer and more potent than existing treatments...

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

Ovid Therapeutics Inc

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

OVID
Ovid Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OVID News

OVIDOvid Therapeutics Inc